Abstract:Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Dekker grant Aortic stenosis (AS) is a narrowing of the aortic valve opening due to calcification and valve thickening. There are currently no pharmacological treatments for AS, and surgical interventions are the only therapies. To understand the molecular mechanisms underlying AS and test new pharmacological agents, advanced calcification models are required. These models need to closely approach native tissue response to stimuli by maintaining the valvular interstitial cells within their native environment. We have recently developed an ex vivo culture model that fulfills this requirement and allows the induction of calcification in slices of human aortic valves. Our goal is to evaluate the applicability of our ex-vivo calcification model as a pre-clinical test system for potential therapies. Diseased aortic valves were dissected, embedded in agarose, then cut into 300-500 um slices using a vibratome. The use of multiple slices from a single patient ensured proper internal controls. To induce calcification, slices were cultured with 3mM phosphate(n=12), and control slices without phosphate (n=11). To investigate molecular modulation of induced calcification, dexamethasone was added to phosphate cultures(n=9). The slices were assessed for calcification using Alizarin Red staining. ImageJ was used to quantify the percentage of alizarin red-positive area. The average thickness was determined using 3DHISTECH software. In the presence of phosphate, a significant increase in the calcification percentage was observed in cultured valve slices compared with cultures without phosphate (p<0.05). Interestingly, within the phosphate-treated group, two sub-groups could be distinguished, one sub-group exhibiting extensive calcification, while the other showed virtually no sign of calcification. Paired comparisons revealed strong effect of dexamethasone depending on the extent of calcification-inducing capability of phosphate in each patient-sample. More precisely, dexamethasone exhibited potent inhibitory effect on calcification in valvular slices from patients where calcification was stimulated in the presence of phosphate. Conversely, dexamethasone exhibited a stimulatory effect on calcification in slices that did not show a stimulation of calcification in the presence of phosphate. This differential effect was strongly correlated with valve thickness.(r=-0.884,p< 0.01). Our novel ex-vivo calcification model for human aortic valves revealed potential presence of patient-specific effects of pharmacological agents. Dexamethasone can have both stimulatory and inhibitory effects on calcification levels, influenced by phosphate response and valve thickness. As thickness might be indicative of the disease stage, this correlation suggests that the direction of compound's effect might depend on disease stage. Hence, proper understanding of potential opposite effects of compounds is crucial in developing novel therapies.

Modulation of calcification of vascular smooth muscle cells in culture by calcium antagonists, statins, and their combination

Aspirin Relieves the Calcification of Aortic Smooth Muscle Cells by Enhancing the Heat Shock Response

Lovastatin inhibits gap junctional communication in cultured aortic smooth muscle cells.

Influence of atorvastatin on ion pump activity of smooth muscle cells and intima proliferation after arterial intimal injury

Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness

Effects of adrenomedullin, C-type natriuretic peptide, and parathyroid hormone-related peptide on calcification in cultured rat vascular smooth muscle cells

Endothelial Cell and Macrophage Regulation of Vascular Smooth Muscle Cell Calcification Modulated by Cholestane-3 Beta, 5 Alpha, 6 Beta-Triol

The Complex Mechanisms and the Potential Effects of Statins on Vascular Calcification: A Narrative Review

The Effect of High Calcium and High Phosphate on Calcification of Rat VSMCs

Statin treatment of patients with calcific aortic valve disease modulates extracellular adenosine metabolism on the cell surface of the aortic valve

Homocysteine potentiates calcification of cultured rat aortic smooth muscle cells.

Β-Glycerophosphate Induced Calcification of Rat Aortic Vascular Smooth Muscle Cells

Novel ex-vivo calcification model for human aortic valves reveals patient-specific effect of compound

Cholestane-3β, 5α, 6Β-Triol Promotes Vascular Smooth Muscle Cells Calcification

Apoptosis induced by simvastatin in rat vascular smooth muscle cell through Ca2+-calpain and caspase-3 dependent pathway.

Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation

Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner

Substrate stiffness promotes vascular smooth muscle cell calcification by reducing the levels of nuclear actin monomers

Effect of crystallization inhibitors on vascular calcifications induced by vitamin D: a pilot study in Sprague-Dawley rats

High Phosphate-Induced JAK-STAT Signalling Sustains Vascular Smooth Muscle Cell Inflammation and Limits Calcification

Vascular Calcification: In Vitro Models under the Magnifying Glass